Under the leadership of the MIATA core team the project went through an intense vetting process that included 2 public consultation periods and 2 public workshops with more than 100 peers from different fields of immunology applying immune monitoring, and from different settings, like academia, biotechnology, biopharma and regulatory agencies (link to contributors).